# Testing the Efficacy of Different Dosages of Lercanidipine to Reduce Hypertensive Blood Pressure in Normal Weight and Obese Patients

> **NCT00160498** · NA · COMPLETED · sponsor: **UCB Pharma** · enrollment: 180 (—)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Lercanidipine

## Key facts

- **NCT ID:** NCT00160498
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2005-08
- **Final completion:** 2005-08
- **Target enrollment:** 180 (—)
- **Last updated:** 2008-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00160498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00160498, "Testing the Efficacy of Different Dosages of Lercanidipine to Reduce Hypertensive Blood Pressure in Normal Weight and Obese Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00160498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*